JP2013533232A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013533232A5 JP2013533232A5 JP2013514194A JP2013514194A JP2013533232A5 JP 2013533232 A5 JP2013533232 A5 JP 2013533232A5 JP 2013514194 A JP2013514194 A JP 2013514194A JP 2013514194 A JP2013514194 A JP 2013514194A JP 2013533232 A5 JP2013533232 A5 JP 2013533232A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- cancer
- composition according
- agent
- taxane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US35233310P | 2010-06-07 | 2010-06-07 | |
| US61/352,333 | 2010-06-07 | ||
| US201161446909P | 2011-02-25 | 2011-02-25 | |
| US61/446,909 | 2011-02-25 | ||
| PCT/US2011/037450 WO2011156119A1 (en) | 2010-06-07 | 2011-05-20 | Combination therapy methods for treating proliferative diseases |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016132221A Division JP2016175947A (ja) | 2010-06-07 | 2016-07-04 | 増殖性疾患を処置するための組み合わせ療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013533232A JP2013533232A (ja) | 2013-08-22 |
| JP2013533232A5 true JP2013533232A5 (enExample) | 2014-07-03 |
| JP6031437B2 JP6031437B2 (ja) | 2016-11-24 |
Family
ID=45098373
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013514194A Active JP6031437B2 (ja) | 2010-06-07 | 2011-05-20 | 増殖性疾患を処置するための組み合わせ療法 |
| JP2016132221A Withdrawn JP2016175947A (ja) | 2010-06-07 | 2016-07-04 | 増殖性疾患を処置するための組み合わせ療法 |
| JP2018025928A Pending JP2018087227A (ja) | 2010-06-07 | 2018-02-16 | 増殖性疾患を処置するための組み合わせ療法 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016132221A Withdrawn JP2016175947A (ja) | 2010-06-07 | 2016-07-04 | 増殖性疾患を処置するための組み合わせ療法 |
| JP2018025928A Pending JP2018087227A (ja) | 2010-06-07 | 2018-02-16 | 増殖性疾患を処置するための組み合わせ療法 |
Country Status (20)
| Country | Link |
|---|---|
| US (4) | US20140155344A1 (enExample) |
| EP (2) | EP3056201A1 (enExample) |
| JP (3) | JP6031437B2 (enExample) |
| KR (1) | KR101850566B1 (enExample) |
| CN (2) | CN103037846B (enExample) |
| AU (2) | AU2011264590B2 (enExample) |
| BR (1) | BR112012031163A2 (enExample) |
| CA (1) | CA2801891C (enExample) |
| CO (1) | CO6670568A2 (enExample) |
| CR (1) | CR20120638A (enExample) |
| IL (2) | IL223190A0 (enExample) |
| MX (1) | MX2012014231A (enExample) |
| MY (1) | MY166014A (enExample) |
| NI (1) | NI201200181A (enExample) |
| NZ (1) | NZ707377A (enExample) |
| PH (1) | PH12012502399A1 (enExample) |
| RU (2) | RU2577278C2 (enExample) |
| SG (2) | SG185798A1 (enExample) |
| WO (1) | WO2011156119A1 (enExample) |
| ZA (1) | ZA201208820B (enExample) |
Families Citing this family (58)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8853260B2 (en) | 1997-06-27 | 2014-10-07 | Abraxis Bioscience, Llc | Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof |
| EP1585548B1 (en) | 2002-12-09 | 2018-06-27 | Abraxis BioScience, LLC | Compositions and methods of delivery of pharmacological agents |
| WO2006089290A1 (en) | 2005-02-18 | 2006-08-24 | Abraxis Bioscience Inc.. | Combinations and modes of administration of therapeutic agents and combination therapy |
| US8735394B2 (en) | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| BRPI0615265A8 (pt) | 2005-08-31 | 2018-03-06 | Abraxis Bioscience Llc | composições compreendendo agentes farmacêuticos pouco hidrossoluíveis e agentes antimicrobianos |
| PT2117520T (pt) | 2006-12-14 | 2018-12-04 | Abraxis Bioscience Llc | Terapia do cancro da mama com base no estado do receptor do hormona com nanoparticulas compreendendo taxane |
| AU2008260447B2 (en) * | 2007-06-01 | 2013-10-10 | Abraxis Bioscience, Llc | Methods and compositions for treating recurrent cancer |
| CN102460167B (zh) | 2009-04-15 | 2015-07-22 | 阿布拉科斯生物科学有限公司 | 不含朊病毒的纳米颗粒组合物和方法 |
| CN104784121A (zh) | 2010-03-26 | 2015-07-22 | 阿布拉科斯生物科学有限公司 | 治疗肝细胞癌的方法 |
| WO2011123393A1 (en) | 2010-03-29 | 2011-10-06 | Abraxis Bioscience, Llc | Methods of enhancing drug delivery and effectiveness of therapeutic agents |
| NZ602385A (en) | 2010-03-29 | 2014-08-29 | Abraxis Bioscience Llc | Methods of treating cancer |
| KR20130088116A (ko) | 2010-06-04 | 2013-08-07 | 아브락시스 바이오사이언스, 엘엘씨 | 췌장암의 치료 방법 |
| MY166014A (en) * | 2010-06-07 | 2018-05-21 | Abraxis Bioscience Llc | Combination therapy methods for treating proliferative diseases |
| BR112013027674A2 (pt) | 2011-04-28 | 2016-09-06 | Abraxis Bioscience Llc | "usos de composições de nanopartículas, composições compreendendo as referidas nanopartículas e cateter com uma agulha". |
| KR20140041505A (ko) | 2011-04-29 | 2014-04-04 | 셀렉타 바이오사이언시즈, 인크. | 조절 b 세포 유도를 위한 관용원성 합성 나노운반체 |
| HRP20200793T1 (hr) | 2011-05-09 | 2020-10-16 | Mayo Foundation For Medical Education And Research | Liječenje raka |
| TW201700103A (zh) | 2011-11-01 | 2017-01-01 | 西建公司 | 利用胞嘧啶核苷類似物之口服配方治療癌症的方法 |
| PT2790675T (pt) | 2011-12-14 | 2019-09-23 | Abraxis Bioscience Llc | Utilização de excipientes poliméricos para a liofilização ou a congelação de partículas |
| CA2917407C (en) | 2012-10-01 | 2023-03-14 | Mayo Foundation For Medical Education And Research | Complexes containing albumin-containing nanoparticles and antibodies to treat cancer |
| US9149455B2 (en) | 2012-11-09 | 2015-10-06 | Abraxis Bioscience, Llc | Methods of treating melanoma |
| US9511046B2 (en) | 2013-01-11 | 2016-12-06 | Abraxis Bioscience, Llc | Methods of treating pancreatic cancer |
| ES2804323T3 (es) | 2013-03-12 | 2021-02-05 | Abraxis Bioscience Llc | Procedimientos de tratamiento de cáncer de pulmón |
| CA2903548A1 (en) | 2013-03-14 | 2014-09-25 | Abraxis Bioscience, Llc | Methods of treating bladder cancer |
| BR112015027291A8 (pt) * | 2013-05-03 | 2019-12-24 | Selecta Biosciences Inc | uso de um imunossupressor que têm uma vida eficaz farmacodinâmica especificada e composição compreendendo o referido imunossupressor |
| WO2014179771A1 (en) * | 2013-05-03 | 2014-11-06 | Selecta Biosciences, Inc. | Dosing combinations for reducing undesired humoral immune responses |
| CA2950926A1 (en) | 2014-06-13 | 2015-12-17 | Mayo Foundation For Medical Education And Research | Albumin-bound paclitaxel nanoparticle/rituximab complexes for treatment of cd20-expressing lymphomas |
| JP6600651B2 (ja) | 2014-06-16 | 2019-10-30 | マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ | 骨髄腫の治療 |
| US20150359810A1 (en) * | 2014-06-17 | 2015-12-17 | Celgene Corporation | Methods for treating epstein-barr virus (ebv) associated cancers using oral formulations of 5-azacytidine |
| WO2016037164A1 (en) | 2014-09-07 | 2016-03-10 | Selecta Biosciences, Inc. | Methods and compositions for attenuating gene expression modulating anti-viral transfer vector immune responses |
| US9446148B2 (en) | 2014-10-06 | 2016-09-20 | Mayo Foundation For Medical Education And Research | Carrier-antibody compositions and methods of making and using the same |
| WO2016089873A1 (en) | 2014-12-02 | 2016-06-09 | Celgene Corporation | Combination therapies |
| US10527604B1 (en) | 2015-03-05 | 2020-01-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel |
| US10705070B1 (en) | 2015-03-05 | 2020-07-07 | Abraxis Bioscience, Llc | Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug |
| EP3313401B1 (en) | 2015-06-29 | 2021-10-06 | Abraxis BioScience, LLC | Nanoparticles comprising sirolimus and an albumin for use in treating epithelioid cell tumors |
| TW201707725A (zh) | 2015-08-18 | 2017-03-01 | 美國馬友醫藥教育研究基金會 | 載體－抗體組合物及其製造及使用方法 |
| TW201713360A (en) | 2015-10-06 | 2017-04-16 | Mayo Foundation | Methods of treating cancer using compositions of antibodies and carrier proteins |
| EP3399861A4 (en) | 2016-01-07 | 2019-08-07 | Mayo Foundation for Medical Education and Research | METHOD FOR THE TREATMENT OF CANCER WITH INTERFERON |
| CN105606824B (zh) * | 2016-01-28 | 2018-04-06 | 山东省药物研究院 | 晚期乳腺癌患者外周血循环肿瘤细胞Her‑2基因的检测方法 |
| US11351254B2 (en) | 2016-02-12 | 2022-06-07 | Mayo Foundation For Medical Education And Research | Hematologic cancer treatments |
| CA3018340A1 (en) | 2016-03-21 | 2017-09-28 | Mayo Foundation For Medical Education And Research | Methods for improving the therapeutic index for a chemotherapeutic drug |
| EP3432926A4 (en) | 2016-03-21 | 2019-11-20 | Mayo Foundation for Medical Education and Research | METHOD FOR REDUCING THE TOXICITY OF CHEMOTHERAPEUTICS |
| US10618969B2 (en) | 2016-04-06 | 2020-04-14 | Mayo Foundation For Medical Education And Research | Carrier-binding agent compositions and methods of making and using the same |
| EP3506950A1 (en) | 2016-09-01 | 2019-07-10 | Mayo Foundation for Medical Education and Research | Methods and compositions for targeting t-cell cancers |
| JP7525999B2 (ja) | 2016-09-01 | 2024-07-31 | マヨ ファウンデーション フォー メディカル エデュケーション アンド リサーチ | キャリアー－ｐｄ－ｌ１結合剤組成物及び癌を処置する為にそれを使用する方法 |
| RU2756892C2 (ru) | 2016-09-06 | 2021-10-06 | Мэйо Фаундейшн Фор Медикал Эдьюкейшн Энд Рисерч | Композиции с паклитакселом, альбумином и связывающим средством и способы их применения и получения |
| CN109843924A (zh) | 2016-09-06 | 2019-06-04 | 梅约医学教育与研究基金会 | 治疗表达pd-l1的癌症的方法 |
| EP3509635A1 (en) | 2016-09-06 | 2019-07-17 | Vavotar Life Sciences LLC | Methods of treating triple-negative breast cancer using compositions of antibodies and carrier proteins |
| EP3522887A4 (en) * | 2016-10-07 | 2020-06-10 | Abraxis BioScience, LLC | METHODS OF TREATING BILARIAN CANCER |
| KR102753928B1 (ko) | 2017-03-11 | 2025-01-14 | 셀렉타 바이오사이언시즈, 인크. | 항염증제, 및 면역억제제를 포함하는 합성 나노담체를 사용한 조합 치료와 관련된 방법 및 조성물 |
| KR20200064112A (ko) | 2017-10-03 | 2020-06-05 | 크리티테크, 인크. | 암의 치료를 위한 면역치료제의 전신 전달과 조합된 항신생물성 입자의 국소 전달 |
| IL277402B1 (en) | 2018-03-20 | 2026-04-01 | Abraxis Bioscience Llc | Methods for treating central nervous system disorders using administration of MTOR inhibitor nanoparticles and albumin |
| CN108498529A (zh) * | 2018-06-20 | 2018-09-07 | 福建师范大学 | 用于肿瘤预防治疗的DNA甲基转移酶抑制剂与cGAMP药物组合物 |
| EP3880191A4 (en) * | 2018-11-13 | 2022-08-10 | Yee, Amy | COMPOSITIONS AND METHODS FOR IMPROVED IMMUNOTHERAPY |
| WO2020243745A1 (en) | 2019-05-29 | 2020-12-03 | Nelum Corporation | Methods and uses for treating cancer |
| EP3980784A1 (en) | 2019-06-04 | 2022-04-13 | Selecta Biosciences, Inc. | Formulations and doses of pegylated uricase |
| KR20220106758A (ko) | 2019-10-28 | 2022-07-29 | 아브락시스 바이오사이언스, 엘엘씨 | 알부민 및 라파마이신의 제약 조성물 |
| EP4196106A1 (en) * | 2020-08-11 | 2023-06-21 | Auxilla Pharmaceuticals and Research LLP | A non-aqueous suspension of anticancer agent |
| TR202018770A2 (tr) * | 2020-11-23 | 2021-02-22 | Ankara Ueniversitesi | Platine Dirençli Over Kanseri Tedavisine Yönelik Yeni Bir İlaç Taşıyıcı Sistem |
Family Cites Families (34)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6537579B1 (en) | 1993-02-22 | 2003-03-25 | American Bioscience, Inc. | Compositions and methods for administration of pharmacologically active compounds |
| US5916596A (en) | 1993-02-22 | 1999-06-29 | Vivorx Pharmaceuticals, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| US6096331A (en) | 1993-02-22 | 2000-08-01 | Vivorx Pharmaceuticals, Inc. | Methods and compositions useful for administration of chemotherapeutic agents |
| US6749868B1 (en) | 1993-02-22 | 2004-06-15 | American Bioscience, Inc. | Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| ES2435944T3 (es) * | 1997-06-27 | 2013-12-26 | Abraxis Bioscience, Llc | Nuevas formulaciones de agentes farmacológicos, métodos para su preparación y métodos para su uso |
| US6613753B2 (en) * | 2001-02-21 | 2003-09-02 | Supergen, Inc. | Restore cancer-suppressing functions to neoplastic cells through DNA hypomethylation |
| EP1585548B1 (en) | 2002-12-09 | 2018-06-27 | Abraxis BioScience, LLC | Compositions and methods of delivery of pharmacological agents |
| US7951780B2 (en) * | 2004-02-25 | 2011-05-31 | Astellas Pharma Inc. | Antitumor agent |
| US20050187148A1 (en) * | 2004-02-25 | 2005-08-25 | Yoshinori Naoe | Antitumor agent |
| AU2006249235B2 (en) * | 2004-05-14 | 2010-11-11 | Abraxis Bioscience, Llc | Sparc and methods of use thereof |
| US20060069060A1 (en) * | 2004-09-27 | 2006-03-30 | Sanjeev Redkar | Salts of decitabine |
| EP2946810A1 (en) * | 2005-02-03 | 2015-11-25 | TopoTarget UK Limited | Combination therapy using an HDAC inhibitor and Vincristine for treating cancer |
| US8735394B2 (en) * | 2005-02-18 | 2014-05-27 | Abraxis Bioscience, Llc | Combinations and modes of administration of therapeutic agents and combination therapy |
| US20070166388A1 (en) * | 2005-02-18 | 2007-07-19 | Desai Neil P | Combinations and modes of administration of therapeutic agents and combination therapy |
| WO2006089290A1 (en) * | 2005-02-18 | 2006-08-24 | Abraxis Bioscience Inc.. | Combinations and modes of administration of therapeutic agents and combination therapy |
| US8034765B2 (en) * | 2005-08-31 | 2011-10-11 | Abraxis Bioscience, Llc | Compositions and methods for preparation of poorly water soluble drugs with increased stability |
| EP1942884A4 (en) * | 2005-11-04 | 2010-01-06 | Merck & Co Inc | METHOD FOR THE TREATMENT OF CANCER WITH SAHA, CARBOPLATIN AND PACLITAXEL AND OTHER COMBINATION THERAPIES |
| US20080057086A1 (en) * | 2006-09-01 | 2008-03-06 | Pharmion Corporation | Colon-targeted oral formulations of cytidine analogs |
| WO2008070011A2 (en) * | 2006-12-04 | 2008-06-12 | Novartis Ag | Combination of an hdac inhibitor and an antimetabolite |
| US20100166869A1 (en) | 2007-05-03 | 2010-07-01 | Desai Neil P | Methods and compositions for treating pulmonary hypertension |
| US20090281047A1 (en) * | 2008-04-03 | 2009-11-12 | Brown Joe Ernest | Compositions And Methods For Immunotherapy |
| CA2721153C (en) | 2008-04-10 | 2018-10-02 | Abraxis Bioscience, Llc | Compositions of hydrophobic taxane derivatives and uses thereof |
| KR20150136137A (ko) | 2008-04-10 | 2015-12-04 | 아브락시스 바이오사이언스, 엘엘씨 | 소수성 탁산 유도체의 조성물 및 그의 용도 |
| HUE055911T2 (hu) * | 2008-05-15 | 2021-12-28 | Celgene Corp | Citidin-analógokat tartalmazó orális készítmények, és eljárások azok alkalmazására |
| US20100055047A1 (en) * | 2008-08-26 | 2010-03-04 | Yiyu Zou | Methods for treating bronchial premalignancy and lung cancer |
| NZ593343A (en) * | 2008-12-11 | 2013-04-26 | Abraxis Bioscience Llc | Combination cancer treatment conprising Abraxane and an inflamatory inhibitor |
| JP2013503174A (ja) * | 2009-08-25 | 2013-01-31 | アブラクシス バイオサイエンス， エルエルシー | タキサンおよびヘッジホッグ阻害剤のナノ粒子組成物を使用する併用療法 |
| WO2011123393A1 (en) * | 2010-03-29 | 2011-10-06 | Abraxis Bioscience, Llc | Methods of enhancing drug delivery and effectiveness of therapeutic agents |
| NZ602385A (en) * | 2010-03-29 | 2014-08-29 | Abraxis Bioscience Llc | Methods of treating cancer |
| JP2013527232A (ja) * | 2010-06-02 | 2013-06-27 | アブラクシス バイオサイエンス， エルエルシー | 膀胱がんの処置方法 |
| KR20130088116A (ko) * | 2010-06-04 | 2013-08-07 | 아브락시스 바이오사이언스, 엘엘씨 | 췌장암의 치료 방법 |
| MY166014A (en) * | 2010-06-07 | 2018-05-21 | Abraxis Bioscience Llc | Combination therapy methods for treating proliferative diseases |
| US9149455B2 (en) * | 2012-11-09 | 2015-10-06 | Abraxis Bioscience, Llc | Methods of treating melanoma |
| US9511046B2 (en) * | 2013-01-11 | 2016-12-06 | Abraxis Bioscience, Llc | Methods of treating pancreatic cancer |
-
2011
- 2011-05-20 MY MYPI2012005255A patent/MY166014A/en unknown
- 2011-05-20 NZ NZ707377A patent/NZ707377A/en unknown
- 2011-05-20 JP JP2013514194A patent/JP6031437B2/ja active Active
- 2011-05-20 RU RU2012156903/15A patent/RU2577278C2/ru active
- 2011-05-20 AU AU2011264590A patent/AU2011264590B2/en active Active
- 2011-05-20 SG SG2012088001A patent/SG185798A1/en unknown
- 2011-05-20 MX MX2012014231A patent/MX2012014231A/es unknown
- 2011-05-20 RU RU2016103126A patent/RU2016103126A/ru not_active Application Discontinuation
- 2011-05-20 PH PH1/2012/502399A patent/PH12012502399A1/en unknown
- 2011-05-20 KR KR1020137000228A patent/KR101850566B1/ko active Active
- 2011-05-20 EP EP16153625.5A patent/EP3056201A1/en not_active Withdrawn
- 2011-05-20 SG SG10201504590WA patent/SG10201504590WA/en unknown
- 2011-05-20 EP EP11792867.1A patent/EP2575774A4/en not_active Withdrawn
- 2011-05-20 BR BR112012031163A patent/BR112012031163A2/pt not_active Application Discontinuation
- 2011-05-20 WO PCT/US2011/037450 patent/WO2011156119A1/en not_active Ceased
- 2011-05-20 CN CN201180038243.9A patent/CN103037846B/zh active Active
- 2011-05-20 CN CN201610059985.4A patent/CN105832703A/zh active Pending
- 2011-05-20 US US13/701,001 patent/US20140155344A1/en not_active Abandoned
- 2011-05-20 CA CA2801891A patent/CA2801891C/en active Active
-
2012
- 2012-11-22 IL IL223190A patent/IL223190A0/en unknown
- 2012-11-22 ZA ZA2012/08820A patent/ZA201208820B/en unknown
- 2012-12-06 NI NI201200181A patent/NI201200181A/es unknown
- 2012-12-14 CR CR20120638A patent/CR20120638A/es unknown
-
2013
- 2013-01-04 CO CO13001846A patent/CO6670568A2/es unknown
- 2013-03-01 US US13/782,992 patent/US20140170228A1/en not_active Abandoned
-
2016
- 2016-07-04 JP JP2016132221A patent/JP2016175947A/ja not_active Withdrawn
- 2016-11-28 US US15/361,851 patent/US20170181998A1/en not_active Abandoned
-
2017
- 2017-03-15 AU AU2017201757A patent/AU2017201757A1/en not_active Abandoned
-
2018
- 2018-02-16 JP JP2018025928A patent/JP2018087227A/ja active Pending
- 2018-08-10 US US16/101,027 patent/US20190167629A1/en not_active Abandoned
-
2019
- 2019-10-03 IL IL26980819A patent/IL269808A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2013527232A5 (enExample) | ||
| RU2012156903A (ru) | Способы комбинированной терапии для лечения пролиферативных заболеваний | |
| Sun et al. | Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system | |
| Socinski et al. | Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung cancer | |
| JP2011079858A5 (enExample) | ||
| Socinski et al. | Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer | |
| NZ708506A (en) | Methods of treating bladder cancer | |
| JP2013503174A5 (enExample) | ||
| JP2012520323A5 (enExample) | ||
| Wang et al. | Gold nanoparticle-mediated delivery of paclitaxel and nucleic acids for cancer therapy | |
| Pham et al. | Strategies for the design of orally bioavailable antileishmanial treatments | |
| JP2016536352A5 (enExample) | ||
| MX2019013701A (es) | Metodos para mejorar suministro de farmacos y efectividad de agentes terapeuticos. | |
| JP2008530248A5 (enExample) | ||
| JP2010209081A5 (enExample) | ||
| HRP20160609T1 (hr) | Postupci liječenja hepatocelularnog karcinoma | |
| JP2015524444A5 (enExample) | ||
| RU2017132877A (ru) | Комбинация антагониста pd-1 и эрибулина для лечения рака | |
| JP2009515901A5 (enExample) | ||
| JP2014520874A5 (enExample) | ||
| CN107073015B (zh) | 用于治疗吸烟者中的非小细胞肺癌的维利帕尼与卡铂和紫杉醇的组合 | |
| JP2015510945A5 (enExample) | ||
| RU2015139515A (ru) | Комбинированное лечение | |
| JP2011500650A5 (enExample) | ||
| Joseph et al. | Radiosensitization in head and neck cancer: do we have an alternative to platins? Role of taxanes |